enfortumab vedotin
astellas,cleveland clinic,seagen
['vedo', 'unite study', ' vedo', 'urothelial', 'urothelial carcinoma', 'enfortumab', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'biomarker', 'advanced uc', 'bladder', 'cleveland ', 'marker ']
unite: biomarkers for ev in pts with advanced uc #gu23 n=170 longer os with high tmb shorter pfs for cdkn2a, cdkn2b or mtap alterations 
Uro Onc @GACancerCenter | Res PD & Ronald W. Lewis MD Chair of Uro Educ @mcg_urology | Digital Media Ed @EUplatinum | #mentalhealth research | @urotoday